Skip to content
For investors

One assessment engine, four products: a tablet assessment for clinics, screening on a phone, wellness programmes, and an API for calls and trials.

Request the deckSee the products

The market

A large problem that is mostly unseen.

57M

people live with dementia worldwide

WHO 2023

8.8M

people with dementia in India

LASI-DAD 2023

75 in 100

are never diagnosed

Alzheimer's Disease International 2021

99 in 100

eligible people never join a trial

USC Schaeffer

Why now

Three things changed.

Treatments need early cases

New Alzheimer's drugs work best early. Finding people early is now the bottleneck.

Tests were not built for India

Paper tests assume schooling and English. Most older Indians have neither.

Tablets are already in clinics

A tablet and a trained nurse are enough. No new hardware, no specialist needed.

Business

Four products, one engine.

Each product reaches a different buyer. All of them lead to a clinician.

ZD Assessment

Available for pilots

The full cognitive assessment, on a tablet.

For: Neurologists & memory clinics, Geriatricians, Psychiatrists

ZD Screening

Coming soon

Check and track your memory and thinking.

For: Adults 50+, Caregivers & families, GPs & family physicians

ZD Wellness

Coming soon

Brain-health programmes for organisations and communities.

For: Employers & HR, Corporate wellness providers, Insurers

ZD API

Coming soon

Cognitive screening over a phone or video call.

For: Pharma clinical ops & CROs, Trial recruitment teams, Telemedicine platforms

Where we are

Honest about the stage.

We will share real, dated numbers in the deck. Nothing here is a performance claim.

  1. Product

    Done

    ZD Assessment built for tablets: 16 core tasks across nine areas, safety checks, report and referral.

  2. Clinical guidance

    Done

    Neurologists and clinical psychologists from SGPGIMS, RMLIMS and Apollomedics.

  3. Backing

    Done

    Funded by MeitY, incubated at ISF-CIED, NVIDIA compute partner.

  4. Pilots

    Next

    Planned in Lucknow with hospitals and 10+ old age homes, after ethics approval.

  5. Validation

    Next

    Clinical validation studies next. The voice and eye engine is in development.

Founders

Four engineers. One R&D team.

Isarar Siddique

Isarar Siddique

Co-founder & CEO

Research strategy & partnerships

LinkedIn
Arshi Niyaz

Arshi Niyaz

Co-founder & CSO

Scientific methods & studies

LinkedIn
Raiyan Siddique

Raiyan Siddique

Co-founder & CTO

AI, engineering & infrastructure

LinkedIn
Jamyang Ugyen Tshomo

Jamyang Ugyen Tshomo

Co-founder & COO

Operations & implementation

LinkedIn
Backed byMeitY, Government of IndiaIntegral Startups Foundation · ISF-CIEDNVIDIA · compute partner

Get in touch

Request the deck and a founder call.

1

Deck

Problem, product, market and plan. Sent by the founders after a short review.

2

Founder call

30 minutes with the founders. Booking link inside the form.

3

Data room

After a call: regulatory plan, study design, financials.

Or write to info@biotechwallah.com

Questions investors ask.

  • No. ZD Assessment is an investigational research prototype, not a diagnostic device. Pilots and clinical validation come first; the regulatory plan is in the data room.

  • Hospitals and clinics for the assessment, employers and insurers for wellness programmes, and pharma, CROs and health platforms for the API.

  • Most older Indians are never assessed, and existing tests assume schooling and English. Built for India, the same engine adapts to other languages.

  • It is in development. It will be validated in clinics before it is used for care.

  • Assessment records are encrypted on the tablet. Voice or eye recordings are collected only with separate consent, under the DPDP Act 2023.